Abstract
Jing Quan Lim, Dachuan Huang, Beng Hooi Phang, Kelila Chai Xin Ye, Nur Ayuni Binte Muhammad Taib, Wei Yi Ng, June Xin Ni Wong, Wendy Lee, Kerry May Lim Huifen, Liang Wei Wang, Rou-Jun Peng, Yi Xia, Yi-Qi Li, Anand Jeyasekharan, Soo Yong Tan, Chee Leong Cheng, Nagavalli Somasundaram, Shin Yeu Ong, Wee-Joo Chng, Sai Mun Leong, Olaf Rötzschke, Lee-Yung Shih, Jie Xiong, Wei-Li Zhao, Soon Thye Lim, Jin-Xin Bei, Chit Fang Cheok, Choon Kiat Ong
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Natural killer-cell malignancies: Diagnosis and treatment
10.1038/sj.leu.2403955 · 2005
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort
10.1002/ajh.26636 · 2022
Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma
10.1158/0008-5472.can-24-0132 · 2024
Whole-genome sequencing identifies responders to pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
10.1038/s41375-020-1000-0 · 2020
Defective Epstein–Barr virus in chronic active infection and haematological malignancy
10.1038/s41564-018-0334-0 · 2019
Association of Epstein-Barr virus genomic alterations with human pathologies
10.1182/blood.2024028055 · 2025
Extranodal NK/T-cell lymphoma: An update of the molecular characterization of the tumor and microenvironment, and its clinical implications
2025
10.1093/emboj/18.11.3064
10.1093/emboj/18.11.3064
Oncogenic activation of STAT3 pathway drives PD-L1 expression in natural killer/T cell lymphoma
10.1182/blood-2018-01-829424 · 2018
10.18632/oncotarget.4906
10.18632/oncotarget.4906
No additional external references are available.